Cart
sales@molnova.com
Dihydro Sanguinarine
CAS No. 3606-45-9
Dihydro Sanguinarine( 1314-Dihydrosanguinarine )
Catalog No. M20339 CAS No. 3606-45-9
Dihydrosanguinarine is a natural compound isolated from the leaves of Macleaya microcarpaand has antifungal and anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 180 | In Stock |
|
| 10MG | 297 | In Stock |
|
| 25MG | 502 | In Stock |
|
| 50MG | 699 | In Stock |
|
| 100MG | 918 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDihydro Sanguinarine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDihydrosanguinarine is a natural compound isolated from the leaves of Macleaya microcarpaand has antifungal and anticancer activity.
-
DescriptionDihydrosanguinarine is a natural compound isolated from the leaves of Macleaya microcarpaand has antifungal and anticancer activity.
-
In Vitro——
-
In Vivo——
-
Synonyms1314-Dihydrosanguinarine
-
PathwayApoptosis
-
TargetCaspase
-
RecptorCaspase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3606-45-9
-
Formula Weight333.34
-
Molecular FormulaC20H15NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO:5.2 mg/mL (15.60 mM)
-
SMILESCN1Cc2c3OCOc3ccc2-c2ccc3cc4OCOc4cc3c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Vrba JDolezel P Vicar Jetal.Cytotoxic activity of sanguinarine and dihydrosanguinarine in human promyelocytic leukemia HL-60 cells[J].Toxicol In Vitro. 2009 Jun;23(4):580-8
molnova catalog
related products
-
Taurohyodeoxycholic ...
Taurohyodeoxycholic acid sodium salt hydrate prevents apoptosis by blocking a calcium-mediated apoptotic pathway as well as caspase-12 activation.?
-
MLT-748
MLT-748 (MLT748) is a potent, selective, allosteric inhibitor of MALT1 paracaspase with IC50 of 5 nM.
-
IDN-7314
A potent, orally active, and irreversible pan-Caspase protease inhibitor with IC50 of <0.08 to 7 nM for inhibition of activated caspase 3, 6 and 8.
